NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England

View Original Notice

Access the full notice on the official portal

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using Direct Award Process C. The contract value is £1,650,000 commencing 01 April 2026 to 31 March 2029. The award decision was made on 16 March 2026 by NHS England North West Specialised Commisisoning Senior Leaders Team: Andrew Bibby, Regional Director of Specialised Commissioning and Health & Justice North West Janine Dyson, Head of Quality Carole Hodgkinsom, Head of Commercial Management Sue McGorry, Director of Nursing Fiona Simmons-Jones, Consultant in Healthcare, Public Health Luoise Sinnott, Head of Acute Strategy and Transformation Carol Stubley, Director of Finance The existing provider is satisfying the existing contract and will likely satisfy the proposed new contract. The provider has been assessed and has passed against the relevant 5 key criteria and mandatory requirements award criteria which were laid out in the procurement documents. There were no conflicts of interests identified.

Organisation

NHS England North West

Manchester, M1 3BN

3

total contracts

—

total value

—

average contract size

Pipeline status

Updated daily